Aviragen Therapeutics Inc
Vaxart is a clinical-stage biotechnology company focused on developing innovative oral recombinant pill vaccines utilizing its proprietary delivery platform. With a commitment to transforming global health, Vaxart aims to provide both mucosal and systemic immunity against prevalent viral diseases through safe, effective, and accessible vaccine solutions.
The company's mission is to advance vaccine science by creating durable immunity options that protect communities worldwide, empowering individuals to lead healthier lives. Vaxart's experienced team and strategic partnerships enhance its capability to accelerate the development of its vaccine candidates, including those targeting norovirus and COVID-19.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

